FDA Chelation Warnings Reflect Growth In Bogus OTCs, Supplements
This article was originally published in The Tan Sheet
Executive Summary
FDA says its Oct. 14 warnings about unapproved autism treatment claims for chelation products marketed as OTCs or dietary supplements reflect a growing problem of fraud in consumer health care product marketing